Digoxin vs Trastuzumab

Digoxin vs Trastuzumab: Overview

This comparison examines the pharmacological differences between Digoxin and Trastuzumab.

Mechanism of Action

Digoxin: Inhibits Na+/K+-ATPase, increasing intracellular calcium.

Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

Pharmacokinetics

Half-life: Digoxin — 36-48 hours; Trastuzumab — 28 days.

Chemical Properties

Molecular Formula: Digoxin — C41H64O14.

Molecular Weight: Digoxin — 780.9430 g/mol.

Type: Digoxin — Small molecule; Trastuzumab — Antibody.